Journals / Türk Biyokimya Dergisi / 2013 / Cilt: 38 - Sayı: 4

A case of Hemoglobin Beckman; An example of hemoglobin variants interfering with HbA1c measurement

Hemoglobin Beckman olgusu; HbA1c ölçümünü interfere eden hemoglobin varyantlarına bir örnek

Pages
369–371
Publication Date
2022-11-05
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: This new case of Hb Beckman is thought to be a modest contribution to the subject of abnormal hemoglobins that interfere the HbA1c measurement

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: It has been known for a long time that the presence of clinically silent hemoglobin (Hb) variants in blood samples could influence the measurement of glycohemoglobin (HbA1c) since these abnormal hemoglobins might interfere with some methodologies.
📊
Key Findings & Data:Material and Methods: The variant was detected during the HbA1c measurement by cation exchange high performance chromatography (CE-HPLC) in a patient with diabetes mellitus.
💡
Conclusion & Impact:Conclusion: This new case of Hb Beckman is thought to be a modest contribution to the subject of abnormal hemoglobins that interfere the HbA1c measurement
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Aim: It has been known for a long time that the presence of clinically silent hemoglobin (Hb) variants in blood samples could influence the measurement of glycohemoglobin (HbA1c) since these abnormal hemoglobins might interfere with some methodologies. In the present study we describe the first case of Hb Beckman in Turkey. Material and Methods: The variant was detected during the HbA1c measurement by cation exchange high performance chromatography (CE-HPLC) in a patient with diabetes mellitus. Since a HbA1c result could not be obtained by this method, the test was repeated by boronate affinity HPLC. Results: Further investigation performed in order to identify the variant revealed heterozygote Hb Beckman 135 GCT-GAT (Ala --> Asp) which explained the inappropriate HbA1c result by CE-HPLC. Conclusion: This new case of Hb Beckman is thought to be a modest contribution to the subject of abnormal hemoglobins that interfere the HbA1c measurement

Özet

Amaç: Klinik belirti vermeyen hemoglobin (Hb) varyantlarının glikohemoglobin (HbA1c) ölçümlerini etkileyebildiği uzun zamandan beri bilinmektedir; zira bu varyantlar bazı ölçüm yöntemleri ile interferans göstermektedir. Bu makalede Türkiye'deki ilk Hemoglobin (Hb) Beckman vakası sunulmaktadır. Gereç ve Yöntemler: Varyant, diyabetli bir hastada katyon değişimli yüksek performans sıvı kromatografisi (CE-HPLC) ile HbA1c ölçümü sırasında tespit edilmiştir. Bu yöntemle HbA1c sonucu elde edilemediğinden ölçüm boronat afinite HPLC yöntemi ile tekrarlanmıştır. Bulgular: Varyantı tanımlamak için yapılan ileri tetkiklerde heterozigot Hb Beckman 135 GCT-GAT (Ala --> Asp) tespit edilmiş ve böylece CE-HPLC ile HbA1c sonucu elde edilememesinin nedeni açıklığa kavuşmuştur. Sonuçlar: Bu yeni Hb Beckman vakasının HbA1c ölçümleri ile interferans yapan anormal hemoglobinlere mütevazı bir katkı olduğu düşünülmektedir

🔖

Cite This Article

YÜCEL, N., MADENCİ, Ö. Ç., DAĞDELEN, L., AKSOY, D., KAPTANAĞASI, A. O. (2022). A case of Hemoglobin Beckman; An example of hemoglobin variants interfering with HbA1c measurement. Türk Biyokimya Dergisi, Cilt: 38 - Sayı: 4, 369–371. https://ajindex.com/articles/621430

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (6)

  1. Rahbar S, Lee T, Asmeron Y. Hb Beckman alpha2 beta2 135(H13 ala-to-glu: a new unstable variant and oxygen affinity. 1991; Blood 78: 204a. Abstract
  2. Kim SY, Kim GYJ, Jo SA, Lee EH, Cho EH, Hwang SH, Lee Y. A novel hemoglobin variant beta 135(H13) Ala > Asp identified in an asymptomatic Korean family by direct sequencing suggesting a new insight into Hb Beckman mutation. Int J Lab Hematol. 2010; 32(1 Pt 1):175-178
  3. Lahousen T, Roller RE, Lipp RW, Schnedl WJ. Silent hemoglobin variants and determination of HbA1c with theHPLC Bio-Rad Variant II. J Clin Pathol. 2002; 55: 699-703
  4. Schnedl WJ, Liebminger A, Roller RE, Lipp RW, Krejs GJ. Hemoglobin variants and determination of glycated hemoglobin (HbA1c). Diabetes Metab Res Rev. 2001; 17(2): 94-98
  5. Sofronescu AG, Williams LM, Andrews DM, Zhu Y. Unexpected hemoglobin HbA1c results. Clin Chem. 2011; 57(2): 153-156
  6. Ohba Y, Miyaji T, Murakami M, Kadowaki S, Fujita T, Oimomi M et al. Himeji or β 140 (H18) Ala-->Asp. A slightly unstable hemoglobin with increased β N-terminal glycation. Hemoglobin 1986; 10: 109-125.